InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: jonnyrocket post# 73505

Monday, 01/02/2012 8:07:17 PM

Monday, January 02, 2012 8:07:17 PM

Post# of 346707
Here is the latest on Dr Haynes. I guess the Infectious Disease Society of America (IDSA) is part of the conspiracy!

Alexander Fleming Award Winners
Current Winner

BARTON F. HAYNES, MD, FIDSA, a thought leader in the fields of human host-pathogen interactions and immune reconstitution, is the recipient of IDSA’s 2011 Alexander Fleming Award for Lifetime Achievement. This award recognizes a career that reflects major contributions to the acquisition and dissemination of knowledge of infectious diseases. Dr. Haynes has been a pioneer in the development of a vaccine for HIV. Through his seminal work in the biology of human thymic epithelium and thymocytes, he has enriched our understanding of human thymic function and established the foundation for thymic cell transplantation for the curative treatment of DiGeorge Syndrome.

Dr. Haynes is the Hanes Professor of Medicine and Immunology and director of the Duke Human Vaccine Institute. His research during the last 10 years has focused on the development of an HIV-1 vaccine. Through his work, Dr. Haynes has demonstrated the importance of tolerance and other immunoregulatory mechanisms in hampering the development of broadly neutralizing antibodies against HIV-1, launching HIV vaccine development into a new direction.

After receiving his medical degree from Baylor College of Medicine in 1973, Dr. Haynes completed his medical residency and internship at Duke Hospital in Durham, North Carolina. From 1975 to 1980, he worked in various roles at the National Institute of Allergy and Infectious Diseases. In July 1980, he began teaching at Duke University in the Departments of Medicine and Microbiology and Immunology. In 2005, he was named director of the National Institutes of Health Center of HIV/AIDS Vaccine Immunology (CHAVI), an international consortium of scientists with the task of developing an effective HIV-1 vaccine. Under his leadership, CHAVI has defined the early T cell responses to HIV and their protective nature, provided the most extensive assessment of HIV antibody responses during acute HIV infection, and developed vaccine candidates that are entering clinical trials. Dr. Haynes has published more than 480 journal articles and served on the editorial boards of numerous scientific publications such as the Journal of Clinical Immunology and Blood.

In recognition of his outstanding contributions to the field of infectious diseases and immunology for more than 30 years—from his groundbreaking research to develop thymus transplantation for T cell deficiency to his work to develop a vaccine for HIV/AIDS—IDSA is proud to present Dr. Haynes with the 2011 Alexander Fleming Award for Lifetime Achievement.

http://www.idsociety.org/Alexander_Fleming_Award_Winners/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News